
Rahul Banarjee/X
Nov 10, 2024, 14:43
Rahul Banarjee: Updated data for eque-cel fully human BCMA CAR-T in myeloma
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, recently shared on X:
“Now out! Updated data for eque-cel (CT103A), fully human BCMA CAR-T in myeloma.
ORR 96% (n=103), 2-yr PFS > 60%, comparatively few ADAs!
BCMA expression required to enter trial, so ORR won’t always be 75% if BCMA-exposed.
14% TRM, mainly infections but 2 Gr5 CRS.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:45
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45